Figure 1.

Schematic of possible therapeutic applications of erythrocyte drug carriers: (1) as a circulating bioreactor, (2) for controlled drug release, and (3) as for targeting RES.

Abbreviations: RES, reticuloendothelial system; RBCs, red blood cells.